Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Terminated × 30 days × Clear all

Phase

Phase 2 54 Phase 1 28 Phase NA 20 Phase 1/2 13 Phase 3 9 Phase 4 2 Phase 2/3 1

Status

Recruiting 43 Active not recruiting 15 Not yet recruiting 13 Suspended 5 Completed 4 Terminated 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

calaspargase pegol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04817761 2026-02-18

SPARK-ALL: Calaspargase Pegol in Adults With ALL

Servier

Phase 2/3 Terminated

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡